BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 15901632)

  • 21. The prognostic value of baseline erosions in undifferentiated arthritis.
    Thabet MM; Huizinga TW; van der Heijde DM; van der Helm-van Mil AH
    Arthritis Res Ther; 2009; 11(5):R155. PubMed ID: 19832979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Do Short and Sustained Periods of American College of Rheumatology/European League Against Rheumatism Remission Predict Functional and Radiographic Outcome in Early Rheumatoid Arthritis Patients With Low Overall Damage Progression?
    Konijn NPC; van Tuyl LHD; Boers M; den Uyl D; Ter Wee MM; Kerstens P; Voskuyl AE; van Schaardenburg D; Nurmohamed MT; Lems WF
    Arthritis Care Res (Hoboken); 2017 Jul; 69(7):989-996. PubMed ID: 27696732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective involvement of ERK and JNK mitogen-activated protein kinases in early rheumatoid arthritis (1987 ACR criteria compared to 2010 ACR/EULAR criteria): a prospective study aimed at identification of diagnostic and prognostic biomarkers as well as therapeutic targets.
    de Launay D; van de Sande MG; de Hair MJ; Grabiec AM; van de Sande GP; Lehmann KA; Wijbrandts CA; van Baarsen LG; Gerlag DM; Tak PP; Reedquist KA
    Ann Rheum Dis; 2012 Mar; 71(3):415-23. PubMed ID: 21953337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study.
    Hetland ML; Stengaard-Pedersen K; Junker P; Lottenburger T; Hansen I; Andersen LS; Tarp U; Svendsen A; Pedersen JK; Skjødt H; Lauridsen UB; Ellingsen T; Hansen GV; Lindegaard H; Vestergaard A; Jurik AG; Østergaard M; Hørslev-Petersen K;
    Ann Rheum Dis; 2008 Jun; 67(6):815-22. PubMed ID: 17878209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Failure in longterm treatment is rare in actively treated patients with rheumatoid arthritis, but may be predicted by high health assessment score at baseline and by residual disease activity at 3 and 6 months: the 5-year followup results of the randomized clinical NEO-RACo trial.
    Rantalaiho V; Kautiainen H; Järvenpää S; Korpela M; Malmi T; Hannonen P; Kaipiainen-Seppänen O; Yli-Kerttula T; Möttönen T; Mustila A; Karjalainen A; Paimela L; Uutela T; Leirisalo-Repo M;
    J Rheumatol; 2014 Dec; 41(12):2379-85. PubMed ID: 25274892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive factors of 5-year health assessment questionnaire disability in early rheumatoid arthritis.
    Combe B; Cantagrel A; Goupille P; Bozonnat MC; Sibilia J; Eliaou JF; Meyer O; Sany J; Dubois A; Daurès JP; Dougados M
    J Rheumatol; 2003 Nov; 30(11):2344-9. PubMed ID: 14677175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: slight improvement over the 1987 ACR criteria.
    Britsemmer K; Ursum J; Gerritsen M; van Tuyl LH; van Schaardenburg D
    Ann Rheum Dis; 2011 Aug; 70(8):1468-70. PubMed ID: 21586440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can we prevent rapid radiological progression in patients with early rheumatoid arthritis?
    Heimans L; Wevers-deBoer KV; Ronday HK; Collée G; de Sonnaville PB; Grillet BA; Huizinga TW; Allaart CF
    Clin Rheumatol; 2015 Jan; 34(1):163-6. PubMed ID: 25431327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Application of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis in Korean patients with undifferentiated arthritis.
    Jung SJ; Kang Y; Ha YJ; Lee KH; Lee SW; Lee SK; Park YB
    Scand J Rheumatol; 2012 May; 41(3):192-5. PubMed ID: 22401568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of multi-biomarker disease activity score and other risk factors with radiographic progression in an observational study of patients with rheumatoid arthritis.
    Li W; Sasso EH; van der Helm-van Mil AH; Huizinga TW
    Rheumatology (Oxford); 2016 Feb; 55(2):357-66. PubMed ID: 26385370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of a clinical practice intervention in early rheumatoid arthritis.
    Descalzo MÁ; Carbonell J; González-Álvaro I; Sanmartí R; Balsa A; Hernandez-Barrera V; Román-Ivorra JA; Ivorra-Cortés J; Lisbona P; Alperi M; Jiménez-Garcia R; Carmona L;
    Arthritis Care Res (Hoboken); 2012 Mar; 64(3):321-30. PubMed ID: 22052599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: a simple model of prediction from a conservatively treated community-based inception cohort.
    Le Loët X; Brazier M; Mejjad O; Boumier P; Daragon A; Gayet A; Pouplin S; Tron F; Zarnitsky C; Vittecoq O; Menard JF; Fardellone P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1739-47. PubMed ID: 20740612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis.
    Kuriya B; Cheng CK; Chen HM; Bykerk VP
    Ann Rheum Dis; 2009 Sep; 68(9):1482-5. PubMed ID: 19015211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study.
    Vermeer M; Kuper HH; Hoekstra M; Haagsma CJ; Posthumus MD; Brus HL; van Riel PL; van de Laar MA
    Arthritis Rheum; 2011 Oct; 63(10):2865-72. PubMed ID: 21647867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort.
    Khanna D; Oh M; Furst DE; Ranganath V; Gold RH; Sharp JT; Park GS; Keystone EC; Paulus HE;
    Arthritis Rheum; 2007 Apr; 57(3):440-7. PubMed ID: 17394230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.
    Combe B; Logeart I; Belkacemi MC; Dadoun S; Schaeverbeke T; Daurès JP; Dougados M
    Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of rheumatoid arthritis development in patients with unclassified arthritis according to the 2010 ACR/EULAR criteria for rheumatoid arthritis.
    Krabben A; Abhishek A; Britsemmer K; Filer A; Huizinga TW; Raza K; van Schaardenburg DJ; van der Helm-van Mil AH
    Rheumatology (Oxford); 2013 Jul; 52(7):1265-70. PubMed ID: 23472043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early clinical response and long-term radiographic progression in recent-onset rheumatoid arthritis: Clinical remission within six months remains the treatment target.
    Legrand J; Kirchgesner T; Sokolova T; Vande Berg B; Durez P
    Joint Bone Spine; 2019 Oct; 86(5):594-599. PubMed ID: 30928534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting.
    Sanmarti R; Gomez A; Ercilla G; Gratacos J; Larrosa M; Suris X; Vinas O; Salvador G; Munoz-Gomez J; Canete JD
    Rheumatology (Oxford); 2003 Sep; 42(9):1044-9. PubMed ID: 12730518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. One year outcome of undifferentiated polyarthritis.
    Jansen LM; van Schaardenburg D; van der Horst-Bruinsma IE; Dijkmans BA
    Ann Rheum Dis; 2002 Aug; 61(8):700-3. PubMed ID: 12117675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.